Eli Lilly (NY: LLY )
525.19 -13.10 (-2.43%) Official Closing Price Updated: 4:10 PM EDT, Oct 3, 2023 Add to My Watchlist
Press Releases about Eli Lilly
Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
October 02, 2023
Via AB Newswire
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
September 20, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress...
Eli Lilly and Company (NYSE: LLY) is a Stock Spotlight on 9/7
September 07, 2023
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
September 20, 2023
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END
Eli Lilly and Company (NYSE: LLY) is a Stock Spotlight on 8/21
August 21, 2023
Eli Lilly and Company (NYSE: LLY) Climbs to New 52-Week High
August 08, 2023
Eli Lilly and Company (NYSE: LLY) Sets New 52-Week High in Tuesday Session
September 05, 2023
Sex Hormones Market to See Huge Growth by 2028 : Novartis, Sanofi, AstraZeneca, Merck
August 30, 2023
Sex Hormones- Comprehensive Study by Type (Progesterone, Testosterone, Drospirenone), Application (Topical, Inhalation, Injection, Others) Players and Region - Global Market Outlook to 2027
Why These 3 Large Caps Are Bucking the August Slump
August 22, 2023
The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023.
Polypeptide.ltd Announces Intent to Expand Tirzepatide and Retatrutide to Production Capacity of High-Quality Peptides.
August 16, 2023
Moscow, Russia--(Newsfile Corp. - August 16, 2023) - Polypeptide.ltd, a frontrunner in delivering exceptional peptide services, proudly announces a substantial...
A handful of large caps have taken things to another level. These three stocks have blown past the herd — and may be market leaders for years to come.
Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results
August 09, 2023
Novo Nordisk's stock surged 16% on preliminary results of clinical trials showing its weight-loss drug Wegovy reduces risk of cardiovascular disease by 20%.
Topics Artificial Intelligence
Exposures Artificial Intelligence
Blockbuster Drugs Market Projected to Show Strong Growth : Celgene, Bristol-Myers Squibb, Pfizer
August 03, 2023
Get an extensive Blockbuster Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Topics Intellectual Property
Exposures Intellectual Property
Lifestyle Drugs Market to See Huge Growth by 2028 : Alkermes, AstraZeneca, Pfizer, BMS
July 25, 2023
Lifestyle Drugs Comprehensive Study by Type (Depression, Dermatology, Sexual dysfunction, Obesity), Application (Children, Adults, Senior Citizens), Form (Tablets, External Use, Injection) Players and...
Exposures Product Safety